Across TCGA pan-cancer cohorts, CABCOCO1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CABCOCO1 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher CABCOCO1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CABCOCO1 expression acts as an unfavorable survival marker.

DLBC, COAD, and ACC are the cancer types where CABCOCO1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Median	II,III,IV	0.065	0.829	<.001	24	view →
COAD	DFS	Median	All	0.160	0.693	.020	6	view →
ACC	DFS	Median	All	0.195	0.748	.003	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: CABCOCO1 tumor-vs-normal RNA expression · all CABCOCO1 data types